Viewing nowCombinationGlarinduo Sustained-release Tablet 5/1000 mg (Linagliptin, Metformin)
Metformin Hydrochloride 1000mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.

MFDS item code 202400627 · Approved 2024.03.22 · Insurance code 628902360
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to assist blood sugar control in patients with type 2 diabetes who are taking linagliptin and metformin together. It is effective in improving blood sugar levels when used in conjunction with dietary therapy and exercise, aiding in the management of diabetes.
The dose of this medicine for antidiabetic therapy should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: linagliptin 5mg and metformin hydrochloride, as extended-release, 2000 mg. This medicine should be taken with food once daily, preferably with the evening meal. To reduce gastrointestinal adverse reactions associated with metformin use, the dose of metformin hydrochloride should be increased gradually. For this medicine 5/1000 mg extended-release tablets, take 1 tablet once daily. Patients taking this medicine 2.5/1000 mg extended-release tablets should take 2 tablets together once daily. 1. Patients not currently receiving metformin therapy: The initial dose of this medicine is a total daily dose of linagliptin 5 mg and metformin hydrochloride 1000mg. The dose of metformin hydrochloride may be increased gradually up to the maximum recommended daily dose of 2000 mg. 2. Patients receiving metformin therapy - For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine is a total daily dose of linagliptin 5 mg and the patient's current dose of metformin hydrochloride. - For patients whose blood glucose is not adequately controlled with combination therapy of metformin and a sulfonylurea, or metformin and insulin, an initial dose of this medicine consisting of a total daily dose of linagliptin 5mg and a dose of metformin hydrochloride similar to the patient's current dose should be considered. When this medicine is administered in combination with insulin or a sulfonylurea, a reduction in the dose of insulin or the sulfonylurea may be necessary to reduce the risk of hypoglycemia. - When switching from an immediate-release metformin formulation to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted as appropriate if necessary. - When switching from combination therapy with linagliptin and extended-release metformin to this medicine, the dose of this medicine should correspond to the patient's current doses of linagliptin and extended-release metformin hydrochloride. Renal impairment Because dose adjustment according to renal function may be necessary, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. No dose adjustment of this medicine is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60mL/min or estimated glomerular filtration rate (eGFR) ≧ 60mL/min/1.73 m2]. In patients with moderate renal impairment (CKD stage 3A), with creatinine clearance (CrCl) of 45mL/min or more and less than 60mL/min, or estimated glomerular filtration rate (eGFR) of 45mL/min/1.73m2 or more and less than 60mL/min/1.73m2, this medicine may be used with metformin hydrochloride dose adjustment as follows, provided it is well tolerated and the patient has no other condition that may increase the risk of lactic acidosis. Since the starting dose of metformin hydrochloride is 500mg or 750mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg. If creatinine clearance (CrCl) decreases to less than 45mL/min or estimated glomerular filtration rate (eGFR) to less than 45mL/min/1.73m2, this medicine should be discontinued immediately.
This medication helps control blood sugar levels. However, it can rarely cause a condition called lactic acidosis, which can be life-threatening; therefore, caution is necessary. Patients who have allergies to any component of this medication, type 1 diabetes, lactic acidosis, severe renal impairment, or hepatic dysfunction should not take this medication. Additionally, it should not be used in cases of severe infections, dehydration, acute myocardial infarction, shock, or any condition that can lead to a rapid decline in renal function. This medication may cause hypoglycemia, so when used with other antidiabetic agents such as insulin or sulfonylureas, blood glucose changes should be closely monitored. Be particularly careful when skipping meals, engaging in excessive exercise, or consuming alcohol, as the risk of hypoglycemia increases. Patients with weakened renal function should have renal function tests before taking this medication, and regularly monitor kidney status during treatment. Patients with compromised heart function must also be cautious when using this medication. When iodine contrast agents are used for radiological examinations, the use of this medication should be discontinued for a certain period before and after the examination, and renal function must be assessed for recovery. Patients scheduled for surgery should discontinue this medication 48 hours prior to surgery and can resume it only after renal function has returned to normal post-surgery. Should there be a sudden onset of severe abdominal pain while taking this medication, acute pancreatitis may be the cause, and a doctor must be informed immediately. Additionally, if there are blisters or rashes on the skin, it may indicate bullous pemphigoid, and the medication should be stopped immediately and a doctor consulted. Long-term use of this medication can lower vitamin B12 levels; therefore, if symptoms of anemia or neurological issues arise, a blood test should be done. This medication should be swallowed whole and not chewed, crushed, or broken, although its outer coating may be expelled unchanged, which is normal. It is advisable not to use this medication during pregnancy or while breastfeeding, and to consult a doctor if planning to become pregnant. Elderly patients may have decreased renal function and therefore, dosage adjustments and regular kidney status checks are necessary. In cases of overdose, gastrointestinal disturbances or lactic acidosis may develop, necessitating an immediate visit to a medical facility, and blood dialysis may be required for drug removal. This medication must be kept out of reach of children and stored away from moisture.
Severe lactic acidosis, hypoglycemia, nasopharyngitis, hypersensitivity reaction, angioedema, urticaria, lactic acidosis, abnormal vitamin B12 absorption test, hypoglycemia, taste disorder, cough, loss of appetite, diarrhea, constipation, nausea, pancreatitis, vomiting, abdominal pain, oral ulcer, abnormal liver function test, hepatitis, pruritus, erythema, rash, lichenoid drug eruption, joint pain accompanied by severe and disability, rhabdomyolysis, increased lipase, increased amylase, constipation, epigastric pain, enterocolitis, intestinal obstruction, gastritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, stuttering, Alzheimer's type dementia, chest pain, fever, facial edema, fatigue, chronic obstructive pulmonary disease, asthma, diabetic foot disease, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina pectoris, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, choledocholithiasis, dizziness, kidney transplant failure, pneumonia, hypercholesterolemia, headache, drowsiness, chest discomfort, asthenia, epistaxis, oropharyngeal pain, dysphonia, allergic rhinitis, exercise-induced dyspnea, productive cough, rhinorrhea, pulmonary mass, joint pain, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased serum triglycerides, increased urine albumin/creatinine ratio, urine leukocyturia, decreased hemoglobin, increased serum potassium, increased serum creatinine, increased serum creatine phosphokinase, elevated ALT, androgenic alopecia, hyperhidrosis, hair loss, dermatitis, anxiety, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, laceration, palpitations, dry eye, glaucoma, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, hepatic steatosis, hearing loss, erectile dysfunction, goiter, anemia, nausea, gastroesophageal reflux disease, gastritis, epistaxis, stomatitis, confused state, nocturia, dermatitis, hypertension, vitreous hemorrhage, fever, ligament sprain, flank pain, myelodysplastic syndrome, vocal cord polyp
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Keeping it at room temperature between 1 to 30 degrees Celsius will help maintain the effectiveness of the medication.
White oval sustained-release film-coated tablet engraved with D 5/1000 on one side
28 tablets (7 tablets/PTPX4)/box, 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 1000mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.
Linagliptin Micronized 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
Linagliptin Micronized 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
Linagliptin Micronized 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationLinagliptin Micronized 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationLinagliptin Micronized 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationLinagliptin Micronized 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationLinagliptin Micronized 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.